| Literature DB >> 21426574 |
Anna R Gagliardi1, Melissa C Brouwers, Valerie A Palda, Louise Lemieux-Charles, Jeremy M Grimshaw.
Abstract
BACKGROUND: Guidelines continue to be underutilized, and a variety of strategies to improve their use have been suboptimal. Modifying guideline features represents an alternative, but untested way to promote their use. The purpose of this study was to identify and define features that facilitate guideline use, and examine whether and how they are included in current guidelines.Entities:
Mesh:
Year: 2011 PMID: 21426574 PMCID: PMC3072935 DOI: 10.1186/1748-5908-6-26
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Studies describing guideline features that may influence use
| Study | Design | Guideline features encouraging use |
|---|---|---|
| Brouwers | Survey of 756 physicians of various specialties between 1999 and 2005 on intended use of 84 cancer guidelines yielding 4,091 surveys | Strong supporting evidence, flexibility of recommendations to local context |
| Wakkee | Questionnaire of 261 dermatologists on characteristics of specific guideline | Concise recommendations |
| Nuckols | Modified Delphi panel of 11 physicians of various specialties | Strong supporting evidence, flexibility of recommendations to patient needs and preferences |
| Francke | Meta-review of 12 systematic reviews on guideline implementation: | |
| 1. 41 cross sectional pre-/post-test studies or controlled trials | Easily accessible, strong supporting evidence, explicit resource implications, flexibility of recommendations to local | |
| 2. 76 survey and qualitative studies | ||
| 3. 91 randomized, cross-over, balanced incomplete block design, controlled before/after, interrupted times series studies | context, concise recommendations | |
| 4. 61 mixed methods studies with focus on randomized or controlled trials | ||
| 5. 23 studies of various quantitative designs | ||
| 6. 235 randomized or controlled trials, controlled before/after or interrupted time series designs | ||
| 7. 40 randomized or controlled trials or before/after studies | ||
| 8. 15 randomized or controlled trials, pre-/post-test studies and one systematic review | ||
| 9. 59 studies of various quantitative or qualitative or mixed design | ||
| 10. 6 randomized controlled trials, time series or before/after studies and 8 studies of mixed design | ||
| 11. 18 ranodmized or controlled trials, before/after or interrupted time series studies | ||
| 12. 20 randomized or controlled trials, case series or case reports | ||
| Cochrane | Systematic review of 256 studies of guideline implementation (178 surveys, 16 focus group studies, 18 interview studies, 44 mixed methods studies) | Easily accessible, strong supporting evidence, flexibility of recommendations to local context, concise recommendations |
| Carlsen | Qualitative analysis of six focus groups involving 27 general practitioners | Trustworthy, suit patients, recommended action is feasible |
| Carlsen | Systematic review of 12 qualitative studies (7 focus group studies, 5 interview studies) evaluating general practitioner attitudes about guidelines | Authorship familiarity, flexibility of recommendations to patient needs and preferences, short and concise, include patient leaflets |
| Jones | Qualitative analysis 28 interviews with physicians and nurses in four intensive care units | Easily accessible, accompanying tools such as checklists, strong supporting evidence, concise recommendations |
| Thomason | Survey and focus groups with 60 physicians and nurses who attended a national conferences | Strong supporting evidence, concise recommendations |
| Sinuff | Qualitative analysis of interviews with 30 physicians and nurses at one hospital | Easily accessible, accompanying tools such as algorithms or pocket cards, concise recommendations |
| McKinlay | Qualitative analysis of interviews with 13 general practitioners from five sites | Authorship familiarity, variety of print and electronic formats |
| Shiffman | Modified Delphi process involving representatives from 22 organizations active in guideline development | Explicit resource implications, suggestions for auxiliary documents for providers or patients, evaluative data collection tools |
| Price | Discourse analysis of laboratory study using clinical scenarios and guidelines of different formats involving three general practitioners and three endocrinologists | Algorithmic guidelines were useful for clinical problem solving, textual guidelines were useful for learning |
| Vinker | Questionnaire of 293 general practitioners and family physicians participating in educational programs over two months | Strong supporting evidence, flexibility of recommendations to patient needs and preferences, concise recommendations |
| Harris | Questionnaire and focus groups with an undisclosed sample drawn from 304 general practitioners based at 16 sites | Accompanying tools such as checklists and standard orders, summaries such as algorithms or diagrams, navigational support such as color-coded tabs, evaluative data collection tools, accessible by computer, information guides for patients |
| Shekelle | Randomized controlled trial of questionnaire on intent to use guidelines among 545 general internists, neurologists and physical medicine specialists who received usual guideline or guideline modified with clinical vignettes | Clinical vignettes describing application of guidelines according to patient needs and preferences |
| Cabana | Systematic review of 76 journal articles on barriers to guideline adherence among physicians | Strong supporting evidence, authorship familiarity, easily accessible, concise recommendations, flexibility of recommendations to patient needs and preferences |
| Grol | Observational study involving 12,880 decisions made by 61 general practitioners based on 12 guidelines with various attributes rated by participants | Strong supporting evidence, concise recommendations, explicit resource implications |
Initial framework of guideline implementability
| Domain | Definition |
|---|---|
| Adaptability | The guideline is available in a variety of versions for different users or purposes. |
| Usability | Content is presented, organized, or formatted to enhance the ease with which the guideline can be employed. |
| Validity | Evidence is summarized and presented such that its quantity and quality are apparent, and it can be easily reviewed, understood, and interpreted. |
| Applicability | Contextual or supplementary clinical information is provided by which to interpret and apply the recommendations for individual patients. |
| Communicability | Information is included to support discussions with patients, or patient involvement in decision making. |
| Accommodation | Costs, resources, competencies and training, technical specifications, and anticipated impact required to accommodate use are identified. |
| Implementation | Strategies for identifying barriers of use, and selecting, planning, and applying promotional strategies are described. |
| Evaluation | Performance measures for audit or monitoring are included. |
Guidelines reviewed by type of organization and clinical topic
| Type of organization | Overall | Diabetes | Hypertension | Leg Ulcer | Heart Failure |
|---|---|---|---|---|---|
| Academic | 1 | 1 | --- | --- | --- |
| Government | 6 | 2 | 2 | 1 | 1 |
| Expert panel or consortium | 2 | 1 | --- | 1 | --- |
| Professional association | 9 | 3 | 2 | 1 | 3 |
| Private, nonprofit | 2 | 1 | --- | --- | 1 |
| Total | 20 | 8 | 4 | 3 | 5 |
Final framework of guideline implementability
| Domain | Element | Examples |
|---|---|---|
| Usability | Navigation | Table of contents |
| Evidence format | Narrative, tabulated or both | |
| Recommendation format | Narrative, graphic (algorithms) or both; Recommendation summary (single list in full or summary version) | |
| Adaptability | Alternate versions | Summary (print, electronic for PDA); Patient (tailored for patients/caregivers); Published (journal) |
| Validity | Number of references | Total number of distinct references to evidence upon which recommendations are based |
| Evidence graded | A system is used to categorize quality of evidence supporting each recommendation | |
| Number of recommendations | Total number of distinct recommendations (sub-recommendations considered same) | |
| Applicability | Individualization | Clinical information (indications, criteria, risk factors, drug dosing) that facilitates application of the recommendations explicitly highlighted as tips or practical issues using sub-titles or text boxes, or summarized in tables and referred to in recommendations or narrative contextualizing recommendations |
| Communicability | Patient education or involvement | Informational or educational resources for patients/caregivers, questions for clinicians to facilitate discussion, or contact information (phone, fax, email or URL) to acquire informational or educational resources |
| Accommodation | Objective | Explicitly stated purpose of guideline (clinical decision making, education, policy, quality improvement) |
| Users | Who would deliver/enable delivery of recommendations (individuals, teams, departments, institutions, managers, policy makers, internal/external agents), who would receive the services (patients/caregivers) | |
| User needs/values | Identification of stakeholder needs, perspectives, interests or values | |
| Technical | Equipment or technology needed, or the way services should be organized to deliver recommendations | |
| Regulatory | Industrial standards for equipment or technology, or policy regarding their use | |
| Human resources | Type and number of health professionals needed to deliver recommended services | |
| Professional | Education, training or competencies needed by clinicians/staff to deliver recommendations | |
| Impact | Anticipated changes in workflow or processes during/after adoption of recommendations | |
| Costs | Direct or productivity costs incurred as a result of acquiring resources or training needed to accommodate recommendations, or as a result of service reductions during transition from old to new processes | |
| Implementation | Barriers/facilitators | Individual, organizational, or system barriers that are associated with adoption |
| Tools | Instructions, tools or templates to tailor guideline/recommendations for local context; Point-of-care templates/forms (clinical assessment, standard orders) | |
| Strategies | Possible mechanisms by which to implement guideline/recommendations | |
| Evaluation | Monitoring | Suggestions for evaluating compliance with organization, delivery and outcomes of recommendations, including program evaluation, audit tools, and performance measures/quality indicators |
Format elements of reviewed guidelines
| Domain/Element | Statistic | Overall | Diabetes (n = 8) | Hypertension (n = 4) | Leg Ulcer (n = 3) | Heart Failure (n = 5) |
|---|---|---|---|---|---|---|
| Adaptability | ||||||
| Journal version | n (%) | 10 (50.0) | 4 (50.0) | 3 (75.0) | 0 (0.0) | 3 (60.0) |
| PDA version | n (%) | 5 (25.0) | 3 (37.5) | 1 (25.0) | 0 (0.0) | 1 (20.0) |
| Short version | n (%) | 9 (45.0) | 0 (0.0) | 3 (75.0) | 2 (66.7) | 4 (80.0) |
| Patient version | n (%) | 4 (20.0) | 0 (0.0) | 2 (50.0) | 0 (0.0) | 2 (40.0) |
| Usability | ||||||
| Table of contents | n (%) | 15 (75.0) | 6 (75.0) | 2 (50.0) | 3 (100.0) | 4 (80.0) |
| Number of pages | mean | 120.2 | 199.5 | 45.8 | 60.7 | 88.4 |
| med | 72.5 | 95.5 | 46.0 | 46.0 | 80.0 | |
| min | 21.0 | 21.0 | 39.0 | 21.0 | 25.0 | |
| max | 878.0 | 878.0 | 52.0 | 115.0 | 163.0 | |
| Number of recommendations | mean | 71.7 | 120.8 | 10.5 | 41.3 | 60.4 |
| med | 41.5 | 126.5 | 9.5 | 39.0 | 43.0 | |
| min | 8.0 | 24.0 | 8.0 | 20.0 | 9.0 | |
| max | 214.0 | 214.0 | 15.0 | 65.0 | 118.0 | |
| Recommendation summary | n (%) | 11 (55.0) | 3 (37.5) | 4 (100.0) | 2 (66.7) | 2 (40.0) |
| Recommendation algorithm | n (%) | 13 (65.0) | 2 (25.0) | 4 (100.0) | 2 (66.7) | 5 (100.0) |
| Validity | ||||||
| Number of references | mean | 452.0 | 849.9 | 128.8 | 111.7 | 278.2 |
| med | 230.5 | 247.0 | 80.0 | 83.0 | 252.0 | |
| min | 15.0 | 15.0 | 24.0 | 72.0 | 218.0 | |
| max | 3,487.0 | 3,487.0 | 331.0 | 180.0 | 347.0 | |
| Evidence graded | n (%) | 19 (95.0) | 7 (85.5) | 4 (100.0) | 3 (100.0) | 5 (100.0) |
| Evidence format | narrative | 15 (75.0) | 6 (75.0) | 4 (100.0) | 2 (66.7) | 3 (60.0) |
| narrative + tabular | 5 (25.0) | 2 (25.0) | --- | 1 (33.3) | 2 (40.0) | |
Content elements of reviewed guidelines
| Domain/Element | Overall | Diabetes | Hypertension (n = 4) | Leg Ulcer | Heart Failure | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| Applicability | ||||||||||
| Individualization | 18 | 90.0 | 6 | 75.0 | 4 | 100.0 | 3 | 100.0 | 5 | 100.0 |
| Communicability | ||||||||||
| Patient informed care | 10 | 50.0 | 4 | 50.0 | 2 | 50.0 | 1 | 33.3 | 3 | 60.0 |
| Accommodation | ||||||||||
| Objectives: | ||||||||||
| Clinical | 20 | 100. | 8 | 100. | 4 | 100.0 | 3 | 100.0 | 5 | 100.0 |
| Education | 1 | 0 | 1 | 0 | --- | --- | --- | --- | --- | --- |
| Policy | --- | 5.0 | --- | 12.5 | --- | --- | --- | --- | --- | --- |
| Quality improvement | 2 | --- | 1 | --- | --- | --- | --- | --- | --- | --- |
| Users | 12 | 60.0 | 5 | 62.5 | 1 | 25.0 | 2 | 66.7 | 4 | 80.0 |
| User needs/values | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.00 | 0 | 0.0 |
| Technical | 9 | 45.0 | 3 | 37.5 | 1 | 25.0 | 1 | 33.3 | 4 | 80.0 |
| Regulatory | 3 | 15.0 | 0 | 0.0 | 3 | 75.0 | 0 | 0.0 | 0 | 0.0 |
| Human resources | 1 | 5.0 | 1 | 12.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Professional | 4 | 20.0 | 0 | 0.0 | 1 | 25.0 | 2 | 66.7 | 1 | 20.0 |
| Impact | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Costs | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Implementation | ||||||||||
| Barriers | 3 | 15.0 | 1 | 12.5 | 2 | 20.0 | 0 | 0.0 | 0 | 0.0 |
| Tailoring instructions | 2 | 10.0 | 0 | 0.0 | 0 | 0.0 | 2 | 66.7 | 0 | 0.0 |
| Point-of-care tools/forms | 6 | 30.0 | 3 | 37.5 | 0 | 0.0 | 2 | 66.7 | 1 | 20.0 |
| Implementation strategies | 9 | 45.0 | 4 | 50.0 | 1 | 25.0 | 2 | 66.7 | 2 | 40.0 |
| Evaluation | ||||||||||
| Evaluation instructions | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Performance measures | 10 | 50.0 | 4 | 50.0 | 2 | 50.0 | 2 | 66.7 | 2 | 40.0 |